115 related articles for article (PubMed ID: 26067114)
21. Comprehensive sequencing of the LRRK2 gene in patients with familial Parkinson's disease from North Africa.
Jasinska-Myga B; Kachergus J; Vilariño-Güell C; Wider C; Soto-Ortolaza AI; Kefi M; Middleton LT; Ishihara-Paul L; Gibson RA; Amouri R; Yahmed SB; Sassi SB; Zouari M; El Euch G; Ross OA; Hentati F; Farrer MJ
Mov Disord; 2010 Oct; 25(13):2052-8. PubMed ID: 20721913
[TBL] [Abstract][Full Text] [Related]
22. A new CHCHD2 mutation identified in a southern italy patient with multiple system atrophy.
Nicoletti G; Gagliardi M; Procopio R; Iannello G; Morelli M; Annesi G; Quattrone A
Parkinsonism Relat Disord; 2018 Feb; 47():91-93. PubMed ID: 29248339
[No Abstract] [Full Text] [Related]
23. NR4A2 mutations are rare among European patients with familial Parkinson's disease.
Wellenbrock C; Hedrich K; Schäfer N; Kasten M; Jacobs H; Schwinger E; Hagenah J; Pramstaller PP; Vieregge P; Klein C
Ann Neurol; 2003 Sep; 54(3):415. PubMed ID: 12953278
[No Abstract] [Full Text] [Related]
24. Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders.
Ogaki K; Koga S; Heckman MG; Fiesel FC; Ando M; Labbé C; Lorenzo-Betancor O; Moussaud-Lamodière EL; Soto-Ortolaza AI; Walton RL; Strongosky AJ; Uitti RJ; McCarthy A; Lynch T; Siuda J; Opala G; Rudzinska M; Krygowska-Wajs A; Barcikowska M; Czyzewski K; Puschmann A; Nishioka K; Funayama M; Hattori N; Parisi JE; Petersen RC; Graff-Radford NR; Boeve BF; Springer W; Wszolek ZK; Dickson DW; Ross OA
Neurology; 2015 Dec; 85(23):2016-25. PubMed ID: 26561290
[TBL] [Abstract][Full Text] [Related]
25. Mitochondrial transcription factor A (TFAM) gene variation in Parkinson's disease.
Alvarez V; Corao AI; Sánchez-Ferrero E; De Mena L; Alonso-Montes C; Huerta C; Blázquez M; Ribacoba R; Guisasola LM; Salvador C; García-Castro M; Coto E
Neurosci Lett; 2008 Feb; 432(1):79-82. PubMed ID: 18248889
[TBL] [Abstract][Full Text] [Related]
26. CHCHD2 is down-regulated in neuronal cells differentiated from iPS cells derived from patients with lissencephaly.
Shimojima K; Okumura A; Hayashi M; Kondo T; Inoue H; Yamamoto T
Genomics; 2015 Oct; 106(4):196-203. PubMed ID: 26188257
[TBL] [Abstract][Full Text] [Related]
27. Alzheimer's disease and Parkinson's disease.
Nussbaum RL; Ellis CE
N Engl J Med; 2003 Apr; 348(14):1356-64. PubMed ID: 12672864
[No Abstract] [Full Text] [Related]
28. A nonsense mutation in CHCHD2 in a patient with Parkinson disease.
Koschmidder E; Weissbach A; Brüggemann N; Kasten M; Klein C; Lohmann K
Neurology; 2016 Feb; 86(6):577-9. PubMed ID: 26764027
[No Abstract] [Full Text] [Related]
29. Pathophysiologic effects of CHCHD2 variants associated with late-onset Parkinson disease.
Kim JM
Hum Mutat; 2017 Aug; 38(8):903. PubMed ID: 28697279
[No Abstract] [Full Text] [Related]
30. Loss of Parkinson's disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c.
Meng H; Yamashita C; Shiba-Fukushima K; Inoshita T; Funayama M; Sato S; Hatta T; Natsume T; Umitsu M; Takagi J; Imai Y; Hattori N
Nat Commun; 2017 Jun; 8():15500. PubMed ID: 28589937
[TBL] [Abstract][Full Text] [Related]
31. Predicted pathogenic missense mutation of PGRN found in a normal control.
Kim HJ; Seong MW; Yun JY; Park SS; Lee JY; Jeon BS
Ann Neurol; 2010 Mar; 67(3):415-6. PubMed ID: 20373362
[No Abstract] [Full Text] [Related]
32. Molecular mechanisms of pathogenesis of Parkinson's disease.
Shadrina MI; Slominsky PA; Limborska SA
Int Rev Cell Mol Biol; 2010; 281():229-66. PubMed ID: 20460187
[TBL] [Abstract][Full Text] [Related]
33. DNAJC13 genetic variants in parkinsonism.
Gustavsson EK; Trinh J; Guella I; Vilariño-Güell C; Appel-Cresswell S; Stoessl AJ; Tsui JK; McKeown M; Rajput A; Rajput AH; Aasly JO; Farrer MJ
Mov Disord; 2015 Feb; 30(2):273-8. PubMed ID: 25393719
[TBL] [Abstract][Full Text] [Related]
34. Autosomal dominant Parkinson's disease caused by SNCA duplications.
Konno T; Ross OA; Puschmann A; Dickson DW; Wszolek ZK
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(Suppl 1):S1-6. PubMed ID: 26350119
[TBL] [Abstract][Full Text] [Related]
35. Identifying PD-causing genes and genetic susceptibility factors: current approaches and future prospects.
Gasser T
Prog Brain Res; 2010; 183():3-20. PubMed ID: 20696312
[TBL] [Abstract][Full Text] [Related]
36. Cyclic adenosine monophosphate response element-binding protein transcriptionally regulates CHCHD2 associated with the molecular pathogenesis of hepatocellular carcinoma.
Song R; Yang B; Gao X; Zhang J; Sun L; Wang P; Meng Y; Wang Q; Liu S; Cheng J
Mol Med Rep; 2015 Jun; 11(6):4053-62. PubMed ID: 25625293
[TBL] [Abstract][Full Text] [Related]
37. Genetics of Substance Use Disorders.
Yu C; McClellan J
Child Adolesc Psychiatr Clin N Am; 2016 Jul; 25(3):377-85. PubMed ID: 27338962
[TBL] [Abstract][Full Text] [Related]
38. Promotion of mitochondrial biogenesis by necdin protects neurons against mitochondrial insults.
Hasegawa K; Yasuda T; Shiraishi C; Fujiwara K; Przedborski S; Mochizuki H; Yoshikawa K
Nat Commun; 2016 Mar; 7():10943. PubMed ID: 26971449
[TBL] [Abstract][Full Text] [Related]
39. Possible association of mitochondrial transcription factor A (TFAM) genotype with sporadic Alzheimer disease.
Günther C; von Hadeln K; Müller-Thomsen T; Alberici A; Binetti G; Hock C; Nitsch RM; Stoppe G; Reiss J; Gal A; Finckh U
Neurosci Lett; 2004 Oct; 369(3):219-23. PubMed ID: 15464268
[TBL] [Abstract][Full Text] [Related]
40. CHCHD2 Is Coamplified with EGFR in NSCLC and Regulates Mitochondrial Function and Cell Migration.
Wei Y; Vellanki RN; Coyaud É; Ignatchenko V; Li L; Krieger JR; Taylor P; Tong J; Pham NA; Liu G; Raught B; Wouters BG; Kislinger T; Tsao MS; Moran MF
Mol Cancer Res; 2015 Jul; 13(7):1119-29. PubMed ID: 25784717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
